« Previous Next »European Journal of Cancer
Volume 42, Issue 15 , Pages 2499-2503, October 2006

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment

Mathilde C.M. Kouwenhoven
- Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
Johan M. Kros
- Department of Pathology, ErasmusMC Rotterdam, The Netherlands
Pim J. French
- Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
Elize M. Biemond-ter Stege
- Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
Wilfried J. Graveland
- Department of Pathology, ErasmusMC Rotterdam, The Netherlands
- Department of Medical Statistics, Daniel den Hoed Oncology Center, Rotterdam, The Netherlands
Martin J.B. Taphoorn
- Department of Neurology, MC Haaglanden-Westeinde Hospital, The Hague, The Netherlands
Alba A. Brandes
- Medical Oncology Department, Neuroncology Unit, Azienda Ospedale-Università-Istituto Oncologico Veneto, Padova, Italy
Martin J. van den Bent
- Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
- Corresponding author: Tel.: +31 10 4391415; fax: +31 10 4391031.